Minoxidil Topical

DRUG2 trials

Sponsors

Industrial Farmacéutica Cantabria, S.A., Dr. dr. Lili Legiawati, SpKK(K)

Conditions

Androgenetic AlopeciaFemale Pattern Baldness

Phase 3

Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia

Active, not recruitingNCT05888922

Industrial Farmacéutica Cantabria, S.A.Androgenetic Alopecia, Female Pattern Baldness

Start: 2024-10-17End: 2026-11-16Target: 520Updated: 2026-09-16

Unknown Phase

Hair Regeneration in Androgenetic Alopecia

Dr. dr. Lili Legiawati, SpKK(K)Androgenetic Alopecia

Start: 2023-08-14End: 2023-11-30Updated: 2023-10-10

Related Papers

Hair regeneration in androgenetic alopecia using secretome of adipose-derived stem cells (ADSC) and minoxidil: a comparative study of three groups.

2025-03-011 citations